Top Markets
Coin of the day
Peak Bio, Inc. Peak Bio, Inc.

Peak Bio, Inc.

PKBO
Ранг среди акций #37553
Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical... Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical development phase, committed to devising treatments for critical, unmet medical needs in the realms of oncology and inflammatory disorders. The company harnesses its unique, proprietary toxin—known as PH-1 or Thailanstatin—a spliceosome modulator, to create its inaugural range of innovative Antibody-Drug Conjugate (ADC) therapies designed for cancer patients facing significant challenges. Additionally, Peak Bio's leading investigational drug, PHP-303, a small molecule, is on the verge of commencing a Phase II dose clinical trial for the rare condition Alpha1 anti-trypsin deficiency (AATD). The company's operations are situated in Palo Alto, California.
Цена акции
$0.07
Последняя синхронизация: 2024-11-12
Рыночная капитализация
$1.62M
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Peak Bio, Inc. (PKBO)

Категория

История цены акций Peak Bio, Inc. (PKBO)
Наивысшая цена закрытия: $0.07 2024-11-01

Наименьшая цена закрытия: $9.71 2021-03-01
История цены акций Peak Bio, Inc. с 2021 по 2026
Годовая динамика цены акций
Год Результативность
2024 -26.66%
2023 -98.23%
2022 -44.81%
2021 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE